Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Clinical trial NCT06585410 · RECRUITING
Trial details
- NCT number
- NCT06585410
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-02
- Primary completion
- 2030-05-03
- Enrollment
- 369
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.